Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jaffe

Showing results (481-490 of 579) with videos related to

Pageof 58
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2013
Déjà vu: Ralstonia mannitolilytica infection associated with a humidifying respiratory therapy device, Israel, June to July 2011C Block, Z Ergaz-Shaltiel, L Valinsky, et al.
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Ophthalmology|September 4, 2020
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 TrialGlenn J Jaffe, Keith Westby, Karl G Csaky, et al.
Investigative Ophthalmology & Visual Science|August 30, 2011
Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degenerationSteffen Schmitz-Valckenberg, Christian K Brinkmann, Florian Alten, et al.
Ophthalmology|April 16, 2019
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular DegenerationPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
Ophthalmology|April 1, 2015
Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments TrialsThomas A Ciulla, Thomas A Cuilla, Gui-Shuang Ying, et al.
Ophthalmology Science|April 7, 2023
Joint Multimodal Deep Learning-based Automatic Segmentation of Indocyanine Green Angiography and OCT Images for Assessment of Polypoidal Choroidal Vasculopathy BiomarkersJessica Loo, Kelvin Y C Teo, Chinmayi H Vyas, et al.
Ophthalmology|November 25, 2019
ReplyPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
JAMA Ophthalmology|January 31, 2020
Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical TrialDrew Scoles, Gui-Shuang Ying, Wei Pan, et al.
Ophthalmology|February 8, 2021
ReplyGlenn J Jaffe, Keith Westby, Karl G Csaky, et al.
Pageof 58

Showing results (481-490 of 579) with videos related to

Sort By:
Pageof 58
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2013
Déjà vu: Ralstonia mannitolilytica infection associated with a humidifying respiratory therapy device, Israel, June to July 2011C Block, Z Ergaz-Shaltiel, L Valinsky, et al.
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Ophthalmology|September 4, 2020
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 TrialGlenn J Jaffe, Keith Westby, Karl G Csaky, et al.
Investigative Ophthalmology & Visual Science|August 30, 2011
Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degenerationSteffen Schmitz-Valckenberg, Christian K Brinkmann, Florian Alten, et al.
Ophthalmology|April 16, 2019
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular DegenerationPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
Ophthalmology|April 1, 2015
Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments TrialsThomas A Ciulla, Thomas A Cuilla, Gui-Shuang Ying, et al.
Ophthalmology Science|April 7, 2023
Joint Multimodal Deep Learning-based Automatic Segmentation of Indocyanine Green Angiography and OCT Images for Assessment of Polypoidal Choroidal Vasculopathy BiomarkersJessica Loo, Kelvin Y C Teo, Chinmayi H Vyas, et al.
Ophthalmology|November 25, 2019
ReplyPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
JAMA Ophthalmology|January 31, 2020
Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical TrialDrew Scoles, Gui-Shuang Ying, Wei Pan, et al.
Ophthalmology|February 8, 2021
ReplyGlenn J Jaffe, Keith Westby, Karl G Csaky, et al.
Pageof 58